Syntheses and crystal structures of two copper(II) complexes derived from 2-bromo-4-chloro-6-[(2-morpholin-4-ylethylimino)methyl]phenol

Two new copper(II) complexes, [CuL₂] (1) and [Cu₂L₂(NCS)₂] · 2CH₃CN (2) (HL = 2-bromo-4-chloro-6-[(2-morpholin-4-ylethylimino)methyl]phenol), have been synthesized and characterized by elemental analyses, infrared spectroscopy, and single-crystal X-ray diffraction. Complex 1 was synthesized by reaction of HL with copper(II) acetate in methanol, while 2 was synthesized by adding ammonium thiocyanate to a methanol/acetonitrile (V : V = 2 : 1) solution of 1. Complex 1 crystallizes in the P2₁/n space group, and the thiocyanato-bridged dinuclear copper(II) complex, 2, crystallizes in the Pbcn space group. The Cu in 1 is four-coordinate square-planar with two imine N and two phenolate O atoms from two Schiff-base ligands. The Cu in 2 is five-coordinate square-pyramidal with NNO donor atoms of one Schiff-base ligand and one N atom of a bridging thiocyanate ligand defining the basal plane, and with one S atom of another bridging thiocyanate ligand occupying the apical position.     

Synthesis and crystal structures of two Schiff base copper(II) complexes derived from 4-chloro-2-[(2-morpholin-4-ylethylimino)methyl]phenol

A centrosymmetric mononuclear copper(II) complex, [Cu(L¹)₂] (I), and a phenolate oxygen-bridged dinuclear copper(II) complex, [Cu₂(L²)₄] (II) (HL¹ = 4-chloro-2-[(2-morpholin-4-ylethylimino)methyl]phenol, HL² = 4-chloro-2-(cyclohexylimino-methyl)phenol), were synthesized and characterized by elemental analyses, IR, and single crystal X-ray diffraction. The crystal of I is monoclinic: space group {ITP}2₁/n, a = 13.396(3), b = 5.339(1), c = 19.740(4) Å, β = 108.64(3), V = 1337.8(5) ų, {ITZ} = 2. The crystal of II is monoclinic: space group P2₁, a = 9.157(2), b = 22.715(4), c = 12.169(2) Å, = 95.28(3), {ITV} = 2520.4(8) Å3, {ITZ}= 2. The Cu atom in I, lying on the inversion center, is four-coordinate in a square planar geometry with two phenolate oxygen and two imine nitrogen atoms. Each Cu atom in II is five-coordinate in a square pyramidal geometry with two phenolate oxygen and two imine nitrogen atoms from two L² ligands defining the basal plane and with one phenolate oxygen atom of another L² ligand occupying the apical position.     

Synthesis and crystal structures of cobalt(III) and zinc(II) complexes derived from 4-chloro-2-[(2-morpholin-4-ylethylimino)methyl]phenol with urease inhibitory activity

A new mononuclear cobalt(III) complex, [CoL₂(N₃)]₂ · CH₃OH (I), and a new mononuclear zinc(II) complex, [ZnLCl(CH₃OH)] (II) (HL = 4-chloro-2-[(2-morpholin-4-ylethylimino)methyl]phenol), were prepared and structurally characterized by elemental analyses, infrared spectroscopy, and single- crystal X-ray diffraction. The crystal of I is monoclinic: space group P2₁/c, a = 18.742(2) Å, b = 15.197(2) Å, c = 25.646(2) Å, β = 125.996(3)°, V = 5909.8(11) ų, Z = 4. The crystal of II is monoclinic: space group P2₁/c, a = 7.257(1) Å, b = 24.707(2) Å, c = 9.637(1) Å, β = 101.557(2)°, V = 1692.9(3) ų, Z = 4. The Co atom in I is in an octahedral coordination, and the Zn atom in II is in a trigonal-bipyramidal coordination. The urease inhibitory test shows that complex I has strong urease inhibitory activity, while complex II has no activity.     

Syntheses and crystal structures of copper(II) and nickel(II) complexes derived from 2-bromo-4-chloro-6-[(2-methylaminoethylimino)methyl]phenol

A new centrosymmetric mononuclear copper(II) complex [Cu(L)₂](ClO₄)₂ (I) and a new centrosymmetric mononuclear nickel(II) complex [Ni(L)₂(MeOH)₂](ClO₄)₂ (II), where L is the zwitterionic ligand 2-bromo-4-chloro-6-[(2-methylammonioethylimino)methyl]phenolate, have been prepared from the Schiff base 2-bromo-4-chloro-6-[(2-methylaminoethylimino)methyl]phenol with copper perchlorate and nickel perchlorate, respectively. The complexes were characterized by elemental analysis, infrared spectra, and single-cyrstal X-ray diffraction (CIF files CCDC nos. 1408054 (I) and 1407973 (II)). Complex I crystallizes in the monoclinic space group P2₁/c with unit cell dimensions a = 7.7736(4), b = 21.608(1), c = 8.5194(4) Å, β = 93.907(2)°, V = 1427.7(1) ų, Z = 2, R ₁ = 0.0546, and wR ₂ = 0.1531. Complex II crystallizes in the monoclinic space group P2₁/c with unit cell dimensions a = 21.324(3), b = 16.821(2), c = 9.425(1) Å, β = 90.114(2)°, V = 3380.5(7) ų, Z = 4, R ₁ = 0.0693, and wR ₂ = 0.1627. The Cu atom in I is in square planar coordination, and the Ni atom in II is in octahedral coordination.     

Synthesis,crystal structures,and antibacterial activities of two copper(II) complexes derived from 1-[(2-morpholin-4-ylethylimino)methyl]-naphthalen-2-ol

A trinuclear complex, [Cu(Cu(μ-Br)₂L)₂], and a dinuclear complex, [Cu₂(μ-Cl)₂L₂], have been synthesized with the tridentate Schiff base 1-[(2-morpholin-4-ylethylimino)methyl]-naphthalen-2-ol (HL), derived from 2-hydroxy-1-naphthyaldehyde and 4-(2-aminoethyl)morpholine. Both complexes have been characterized by physicochemical and spectroscopic methods. [Cu(Cu(μ-Br)₂L)₂] is a centrosymmetric bromide and phenolate oxygen-bridged trinuclear compound, while complex [Cu₂(μ-Cl)₂L₂] is a centrosymmetric-chloride-bridged dinuclear compound. The central Cu(II) atom in [Cu(Cu(μ-Br)₂L)₂] is six-coordinated in an octahedral coordination, while other Cu(II) atoms in both complexes are five-coordinated in square-pyramidal coordinations. Both complexes and HL were tested in vitro for their antibacterial activities.     

Synthesis, crystal structures, and biological activity of zinc(II) complexes derived from 4-bromo-2-[(3-diethylaminopropylimino)methyl]phenol

Two new Schiff base zinc(II) complexes, [ZnBr₂L] (I) and [ZnCl₂L] (II), where L is 4-bromo-2-[(3-diethylaminopropylimino)methyl]phenol, were synthesized and characterized by physico-chemical methods and single crystal X-ray diffraction. The crystal of I is monoclinic: space group P2₁/n a = 7.250 (2), b = 16.136 (3), c = 15.802 (3) Å, β = 90.027 (3)°, V = 1848.6 (7) ų, Z = 4. The crystal of II is monoclinic: space group P2₁/n, a = 7.177 (3), b = 15.970 (4), c = 15.689 (3), β = 91.674 (3)°, V = 1797.5 (9) ų, Z = 4. The Zn atom in each complex is four-coordinated by one phenolate O and one imine N atoms of the Schiff base ligand and two halide atoms, forming a tetrahedral coordination. The urease inhibitory activities of the complexes were evaluated.     

Syntheses,crystal structures,and urease inhibitory properties of copper(II) and zinc(II) complexes with 2-bromo-4-chloro-6-[(2-dimethylaminoethylimino)methyl]phenol

A new copper(II) complex, [CuL(μ _1,1-N₃)] _n (1), and a new zinc(II) complex, [ZnL(μ ₂-acetato-O, O′)₂] _n (2) (HL = 2-bromo-4-chloro-6-[(2-dimethylaminoethylimino)methyl]phenol), were prepared and characterized by elemental analyses, infrared spectroscopy, and single-crystal X-ray diffraction. Complex 1 is an end-on azide-bridged polynuclear copper(II) complex and 2 is a syn–anti bidentate acetate-bridged polynuclear zinc(II) complex. Each metal in the complex is five-coordinate with square-pyramidal geometry. Complex 1 shows good urease inhibitory properties, while 2 does not.     

Synthesis,crystal structures,and antimicrobial activity of two thiocyanato-bridged dinuclear copper(II) complexes derived from 2,4-dibromo-6-[(2-diethylaminoethylimino)methyl]phenol and 4-nitro-2-[(2-ethylaminoethylimino)methyl]phenol

A pair of structurally similar thiocyanato-bridged dinuclear Cu(II) complexes derived from the Schiff bases 2,4-dibromo-6-[(2-diethylaminoethylimino)methyl]phenol and 4-nitro-2-[(2-ethylaminoethylimino)methyl]phenol has been prepared and characterized by physico-chemical and spectroscopic methods. Each Cu atom is five-coordinate in a square-pyramidal geometry, with one O and two N atoms of one Schiff base ligand and one N atom of a bridging thiocyanate ligand defining the basal plane, and with one terminal S atom of another bridging thiocyanate ligand occupying the apical position. Antimicrobial activities of the Schiff bases and the two complexes have been tested. Electronic supplementary material  The online version of this article (doi:) contains supplementary material, which is available to authorized users.     

Zinc(II) and nickel(II) complexes derived from 2-bromo-6-[(2-Isopropylaminoethylimino)methyl]phenol: Synthesis,structures, and antimicrobial activity

The Schiff base 2-bromo-6-[(2-isopropylaminoethylimino)methyl]phenol (HL), derived from 3-bromosalicylaldehyde with N-isopropylethane-1,2-diamine, and its zinc(II) and nickel(II) complexes [Zn(HL)₂(NCS)₂] (I) and [Ni(HL)₂(N₃)₂)] · 0.25H₂O (II) have been prepared and characterized by elemental analyses, IR, and single crystal X-ray crystallographic determination. The crystal of I is orthorhombic: space group Pbca, a = 13.6928(9), b = 9.7203(6), c = 22.926(1) Å, V = 3051.4(3) Å^{3, Z} = 4. The crystal of II is triclinic: space group $P\bar 1$ , a} = 8.0212(7), b = 12.744(1), c = 15.590(2) Å, α = 104.802(3)°, β = 90.561(3)°, γ = 103.130(3)°, V = 1496.6(2) Å^{3, Z} = 1. The zwitterionic Schiff base ligands coordinate to the metal atoms through phenolate O, imine N, and amine N atoms. Each metal atom in the complexes is in octahedral coordination. The effect of these complexes on the antimicrobial activity against Staphylococcus aureus, Escherichia coli, and Candida albicans were studied.     

Synthesis,crystal structures,and antimicrobial activity of a pair of isostructural dinuclear copper(II) complexes derived from 4-nitro-2-[(2-diethylaminoethylimino)methyl]phenol

A pair of isostructural azido- or thiocyanato-bridged centrosymmetric dinuclear copper(II) complexes, [Cu₂L₂(μ_1,3-N₃)₂] (1) and [Cu₂L₂(μ_1,3-NCS)₂] (2), derived from the Schiff base ligand 4-nitro-2-[(2-diethylaminoethylimino)methyl]phenol (HL), have been synthesized and characterized by elemental analysis, IR spectra and single crystal X-ray diffraction. Each Cu atom in the complexes is five-coordinate in a square pyramidal geometry by one O and two N atoms of one Schiff base ligand, and by two terminal donor atoms from two bridging azide or thiocyanate ligands. Both the azide and thiocyanate ligands adopt end-to-end bridging mode in the complexes. The distance between the two copper atoms is 5.205(2) Å for (1) and 5.515(2) Å for (2). The antimicrobial activity of the complexes has been tested.     

Crystal structures of bis(AZIDO)bis(2-morpholin-4-ylethylamino)copper(II) and bis{2,4-dibromo-6-[(2-morpholin-4-ylethylimino)methyl] phenolato}copper(II)

Two new copper(II) complexes [Cu(MEA)₂(N₃)₂] (1) and [Cu(BMP)₂] (2), where MEA and BMP are 2-morpholin-4-ylethylamine and 2,4-dibromo-6-[(2-morpholin-4-ylethylimino)methyl]phenolate respectively, are prepared and characterized using elemental analysis, FT-IR spectroscopy, and X-ray single crystal diffraction. The crystal of 1 belongs to the triclinic system, space group P-1, with a = 6.661(2) Å, b = 8.440(3) Å, c = 8.913(3) Å, α = 102.032(3)°, β = 107.899(2)°, γ = 98.242(3)°, V = 454.6(3) ų, Z = 1, D _c = 1.490 g/cm³, R ₁ = 0.0226, and wR ₂ = 0.0564. The crystal of 2 belongs to the monoclinic system, space group P2₁/c, with α = 7.0707(7) Å, b = 15.438(1) Å, c = 14.227(1) Å, β = 96.659(2)°, V = 1542.5(3) ų, Z = 2, D _c = 1.821 g/cm³, R ₁ = 0.0437, and wR ₂ = 0.1041. In each complex, the Cu atom is in a square planar coordination. The molecules of 1 are linked through intermolecular N-H...N and N-H...O hydrogen bonds to form layers parallel to the ab plane. The molecules of 2 are linked through intermolecular C-H...Br hydrogen bonds to form a 3D network.     

Synthesis,crystal structures,and antibacterial activity of copper(II) and cobalt(III) complexes derived from 2-[(2-dimethylaminoethylimino)methyl]-4-methylphenol

A new tetranuclear copper(II) complex (I) and a new mononuclear cobalt(III) complex (II) have been synthesized from the Schiff base compound 2-[(2-dimethylaminoethylimino)methyl]-4-methylphenol. The complexes have been characterized by physico-chemical and spectroscopic methods, as well as single crystal X-ray determination (CIF files CCDC nos. 1447778 (I) and 1447779 (II)). The Cu atoms in complex I are in square pyramidal coordination, and the Co atom in complex II is in octahedral coordination. Crystal structures of the complex are stabilized by hydrogen bonds and π···π interactions. The complexes and the Schiff base compound were assayed for antibacterial activities against three Gram-positive bacterial strains (B. subtilis, S. aureus, and St. faecalis) and three Gram-negative bacterial strains (E. coli, P. aeruginosa, and E. cloacae) by MTT method. As a result, the complexes showed effective antimicrobial activity against the microorganisms tested.     

Synthesis and crystal structures of two zinc(II) complexes derived from 4-bromo-2-(cyclopentyliminomethyl)phenol with different solvents

Two new mononuclear zinc(II) complexes, [ZnL₂] (I) and [ZnL₂] · 2MeOH (II) (HL = 4-bromo-2-(cyclopentyliminomethyl)phenol), were synthesized by the reaction of the Schiff base HL with zinc acetate in ethanol and methanol solutions, respectively. Both complexes were characterized by elemental analyses and single-crystal X-ray diffraction. The crystal of I is orthorhombic: space group Pbca, a = 14.711(3), b = 13.223(3), c = 24.870(5) Å, V = 4837.8(18) ų, Z = 8. The crystal of II is monoclinic: space group C2/c, a = 20.581(5), b = 10.660(3), c = 15.428(4) Å, β = 119.919(3)°, V = 2933.7(13) ų, Z = 4. The Zn atom in each complex is four-coordinated by two imine N and two phenolic O atoms, forming a tetrahedral geometry. Complex II possesses crystallographic two-fold rotation axis symmetry.     

Syntheses and structures of 2-bromo-4-chloro-6- (cyclopropyliminomethyl)phenol and its zinc(II) complex

A new Schiff-base ligand 2-bromo-4-chloro-6-(cyclopropyliminomethyl)phenol and its zinc(II) complex have been synthesized and characterized by elemental analyses, infrared spectroscopy, ¹H NMR, ¹³C NMR, and single crystal X-ray determinations. The ligand and the complex crystallized in the space groups Pnma and P2₁/c, respectively. In the complex, the Zn atom is four-coordinate tetrahedral coordination with two imine N and two phenolate O atoms from two Schiff-base ligands. The bond lengths related to the donor atoms in the complex are different from those in the ligand. The coordination of the ligand to the zinc also was supported by IR spectra.     

Synthesis, structures, and antimicrobial activity of nickel(II) and Zinc(II) complexes with 5-methoxy-2-[(3-methylaminopropylimino)methyl]phenol

The Schiff base 5-methoxy-2-[(3-methylaminopropylimino)methyl]phenol (MMP) derived from 4-methoxysalicylaldehyde and N-methylpropane-1,3-diamine and its nickel(II) and zinc(II) complexes [Ni(MMP)₂(NCS)₂] (I) and [ZnCl₂(MMP)] (II), have been prepared and characterized by elemental analyses, IR, and single crystal X-ray crystallographic determination. The crystal of I is monoclinic: space group P2₁/c, a = 9.0488(8), b = 12.7768(12), c = 12.9232(11) Å, β = 101.927(5)°, V = 1461.9(2) ų, Z = 2. The crystal of II is orthorhombic: space group Pbca, a = 11.6991(7), b = 13.2839(8), c = 20.4451(12) Å, V = 3177.4(3) ų, Z = 8. The Schiff base coordinates to the metal atoms through the phenolate O and imine N atoms. The effect of these complexes on the antimicrobial activity against Staphylococcus aureus, Escherichia coli, and Candida albicans were studied.     

Solvent-influenced syntheses and crystal structures of two azido-bridged polynuclear copper(II) complexes derived from 2-[(3-methylaminopropylimino)methyl]phenol with urease inhibitory activities

An end-on azido-bridged dinuclear Cu(II) complex, [Cu₂L₂(μ_1,1–N₃)₂]·CH₃OH, and an end-on azido-bridged polynuclear Cu(II) complex, [CuL(μ_1,1–N₃)]_n, derived from the Schiff base 2-[(3-methylaminopropylimino)methyl]phenol (HL), were synthesized and characterized by physico-chemical and spectroscopic methods. The two complexes were synthesized and crystallized with different solvents, methanol for [Cu₂L₂(μ_1,1–N₃)₂]·CH₃OH and ethanol for [CuL(μ_1,1–N₃)]_n. The Cu atom in each complex is five-coordinate in a square pyramidal geometry with one O and two N atoms of L, and one N atom of an azide ligand defining the basal plane, and with one N atom of another azide ligand occupying the apical position. The urease inhibitory activities of both complexes were evaluated.     

The unprecedented preparation of dinuclear zinc(II) complexes from 4-halido-2-[(3-cyclohexylaminopropylimino)methyl]phenol

Three new centrosymmetric trinuclear nickel(II) and manganese(II) complexes, Ni[Ni(CH(3)COO)(CPA)](2) (1), Ni[Ni(CH(3)COO)(BPA)](2) (2), Mn[Mn(CH(3)COO)(BPA)](2) (3), where H(2)CPA = N,N'-bis(5-chlorosalicylidene)-1,3-propanediamine, H(2)BPA = N,N'-bis(5-bromosalicylidene)-1,3-propanediamine, and two new centrosymmetric dinuclear zinc(II) complexes, [Zn(2)(CMP)(2)] (4) and [Zn(2)(BMP)(2)] (5), where H(2)CMP = 4-chloro-2-{[3-(5-chloro-2-hydroxybenzyl)aminopropylimino]methyl}phenol, and H(2)BMP = 4-bromo-2-{[3-(5-bromo-2-hydroxybenzyl)aminopropylimino]methyl}phenol, have been prepared from the Schiff bases derived from 5-halido-substituted salicylaldehydes with N-hexylpropane-1,3-diamine under solvothermal conditions. The complexes have been characterised by elemental analysis, IR spectroscopy and single-crystal X-ray diffraction studies. The complexes 1, 2, and 3 crystallise in the monoclinic space group P2(1)/c with cell dimensions a = 9.347(1), b = 11.507(2), c = 18.539(2) ?, β = 93.774(2)°, Z = 2 (for 1), a = 9.111(4), b = 12.089(6), c = 18.724(8) ?, β = 92.117(7)°, Z = 2 (for 2), and a = 11.328(2), b = 22.468(5), c = 8.270(2) ?, β = 93.74(3)°, Z = 2 (for 3), while complexes 4 and 5 crystallise in the triclinic space group P1, with cell dimensions a = 7.483(1), b = 9.990(2), c = 12.155(2) ?, α = 75.27(3), β = 85.00(3), γ = 73.82(3)°, Z = 1 (for 4), and a = 7.008(1), b = 10.081(2), c = 13.095(3) ?, α = 100.62(3), β = 95.51(3), γ = 104.03(3)°, Z = 1 (for 5). It is interesting that the mono-Schiff bases 4-chloro-2-[(3-cyclohexylaminopropylimino)methyl]phenol (HCCP) and 4-bromo-2-[(3-cyclohexylaminopropylimino)methyl]phenol (HBCP) used to prepare the nickel(II) and manganese(II) complexes were transferred to bis-Schiff bases H(2)CPA and H(2)BPA in the complexes 1, 2, and 3, while the mono-Schiff bases HCCP and HBCP used to prepare the zinc(II) complexes were transferred to novel ligands H(2)CMP and H(2)BMP, bearing the unexpected, newly formed carbon-nitrogen single bond.     

Synthesis and characterization of two acetato-bridged dinuclear copper(II) complexes with 4-bromo-2-((4 or 6-methylpyridin-2-ylimino)methyl)phenol as ligand

The synthesis and characterization of two new acetato-bridged dinuclear copper(II) complexes are described. Both compounds have the general formula [Cu(L)(µ-O₂C–CH₃)]₂, in which L = 4-bromo-2-((4-methylpyridin-2-ylimino)methyl)phenol or 4-bromo-2-((6-methylpyridin-2-ylimino)methyl)phenol. The title compounds consist of dinuclear units with bridging acetato groups and a ligand linked to each copper via the phenol oxygen and nitrogen. Both compounds were synthesized in a one-step reaction and characterized by elemental analysis, Fourier transform infrared (FTIR), electron spin resonance (ESR), and electronic spectra and by room temperature magnetic moments. The compounds exhibit antiferromagnetic interactions at room temperature. UV-Vis spectra show four absorptions attributed to d–d transitions of copper, ligand → metal charge transfer and π → π* or n → π* transitions of ligand. The FTIR spectra indicate a Cu₂O₄C₂ ring vibration. Both complexes show room temperature magnetic moments of about 1.6 B.M. per copper. The X-band ESR studies indicate a weak half-field band, characteristic of the Cu(II)–Cu(II) dimer, observed at 1552 and 1558 G for the complexes, strongly suggesting that the hyperfine structure arises from a spin triplet species. The spectra of frozen samples in DMSO or DMF at liquid nitrogen temperature show a typical Δm = 1 transition.     

Crystal structures of nitrato-{4-bromo-2-[(2-hydroxyethylimion)methyl]phenolo}-(3,5-Dibromopyridine)copper and nitrato-{2,4-dibromo-6-[(2-hydroxyethylimino)methyl]phenolo}-(3,5-dibromopyridine)copper

The crystal structures of nitrato-{4-bromo-2-[2-hydroxyethylimino)methyl]phenolo}-(3,5-dibromopyridine)copper (I) and nitrato-{2,4-dibromo-6-[(2-hydroxyethylimino)methyl]phenolo}-(3,5-dibromopyridine)copper (II) are determined. The crystals of compound I are orthorhombic: a = 14.157(3) Å, b = 15.420(3) Å, c = 17.494(4) Å, space group Pbca, Z = 8, R = 0.067. The crystals of compound II are monoclinic: a = 10.675 Å, b = 13.973 Å, c = 14.007 Å, β = 111.92°, space group P2₁/n, Z = 4, R = 0.0464. In the structures of compounds I and II, the copper atom coordinates, correspondingly, singly deprotonated 4-bromo-2-[(2-hydroxyethylimino)methyl]phenol and 2,4-dibromo-6-[(2-hydroxyethylimino)methyl]phenol molecules, and 3,5-dibromopyridine, and the nitrate ion. The coordination polyhedron of the copper ion in complexes I and II is a slightly distorted tetragonal pyramid. The bases of the pyramids are formed by the imine and pyridine nitrogen atoms and the phenolic and alcoholic oxygen atoms, and the axial vertices are occupied by the oxygen atoms of the monodentate nitrato groups. In the complexes under study, the six-membered metallocycles have asymmetric gauche conformation. In crystal, complexes I are united, due to the slip plane a, through bifurcate hydrogen bonds into infinite chains along the direction [100]. Complexes II in crystal form two-dimensional networks by means of hydrogen bonds.     

The anion-directed self-assembly of manganese complexes derived from 2-ethoxy-6-[(2-phenylaminoethylimino)methyl]phenol

The mixed valence manganese(II/IV) complex, [Mn^IIL₂(MeOH)₂]·[Mn^IVL₂(OAc)₂]·2(MeOH) (1), and the chloride-bridged 1D polymeric manganese(III) complex, [Mn^IIIL₂(μ-Cl)]_n (2), where L is the deprotonated form of 2-ethoxy-6-[(2-phenylaminoethylimino)methyl]phenol (HL), have been prepared and structurally characterized by single-crystal X-ray diffraction analysis and IR spectra. The Mn atoms in both complexes are octahedrally coordinated. The self-assembly of the complex structures is apparently directed by the anions of the manganese salts.